Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Heart Lung Transplant. 2013 Aug 13;32(10):10.1016/j.healun.2013.07.004. doi: 10.1016/j.healun.2013.07.004

Figure 5.

Figure 5

Kaplan-Meier curves of survival comparing those with antibody mediated rejection (AMR) by all four criteria versus those with allograft dysfunction and donor specific antibodies (DSA) without C4d deposition. Note that it is not clear that the 26 patients without C4 deposition all had the same syndrome, but likely represents a heterogeneous group with different causes of allograft dysfunction.